Free Trial

Raymond James (RJF) Stock Forecast & Price Target

Raymond James logo
$165.76 +0.31 (+0.19%)
(As of 12/4/2024 ET)

Raymond James - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
4

Based on 12 Wall Street analysts who have issued ratings for Raymond James in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 8 have given a hold rating, and 4 have given a buy rating for RJF.

Consensus Price Target

$140.91
-14.99% Downside
According to the 12 analysts' twelve-month price targets for Raymond James, the average price target is $140.91. The highest price target for RJF is $152.00, while the lowest price target for RJF is $126.00. The average price target represents a forecasted downside of -14.99% from the current price of $165.76.
Get the Latest News and Ratings for RJF and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Raymond James and its competitors.

Sign Up

RJF Analyst Ratings Over Time

TypeCurrent Forecast
12/5/23 to 12/4/24
1 Month Ago
11/5/23 to 11/4/24
3 Months Ago
9/6/23 to 9/5/24
1 Year Ago
12/5/22 to 12/5/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
9 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$140.91$140.91$129.89$118.67
Forecasted Upside-14.99% Downside-3.06% Downside10.47% Upside12.82% Upside
Consensus Rating
Hold
Hold
Hold
Hold

RJF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RJF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Raymond James Stock vs. The Competition

TypeRaymond JamesFinance CompaniesS&P 500
Consensus Rating Score
2.33
2.49
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside-14.98% Downside10.04% Upside7.68% Upside
News Sentiment Rating
Positive News

See Recent RJF News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/30/2024TD Cowen
5 of 5 stars
 Boost TargetHold ➝ Hold$128.00 ➝ $150.00+0.73%
10/29/2024Morgan Stanley
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$132.00 ➝ $145.00-2.13%
10/24/2024Bank of America
4 of 5 stars
 Boost TargetBuy ➝ Buy$136.00 ➝ $152.00+3.73%
10/24/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Ryan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Outperform ➝ Market Outperform$146.00 ➝ $150.00+2.36%
10/24/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Brown
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$140.00 ➝ $152.00+2.98%
10/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$125.00 ➝ $142.00-2.86%
10/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$123.00 ➝ $126.00-0.51%
7/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$137.00 ➝ $135.00+16.84%
7/9/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$138.00 ➝ $135.00+13.76%
7/8/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Chubak
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Peer Perform
4/25/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$132.00 ➝ $131.00+10.55%
4/11/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$112.00 ➝ $132.00+5.14%
1/26/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$119.00 ➝ $116.00-1.79%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:23 PM ET.


Should I Buy Raymond James Stock? RJF Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, November 25, 2024. Please send any questions or comments about these Raymond James pros and cons to contact@marketbeat.com.

Raymond James
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Raymond James:

  • Raymond James has recently seen a significant increase in its stock price, currently trading at $165.18, reflecting strong market confidence and potential for further growth.
  • Institutional investors own 83.83% of Raymond James' stock, indicating strong backing and confidence from major financial players, which can lead to stability and growth.
  • Analysts have raised their price targets for Raymond James, with several firms setting targets between $140.00 and $152.00, suggesting a positive outlook for the company's future performance.
  • The company has demonstrated robust growth, with recent acquisitions by institutional investors, such as Van ECK Associates Corp acquiring 21,021 shares valued at approximately $2.57 million, indicating strong interest in the stock.
  • Raymond James has a solid financial foundation, with a current ratio of 1.02, indicating that it has enough assets to cover its liabilities, which is a positive sign for investors looking for stability.

Raymond James
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Raymond James for these reasons:

  • Despite the positive outlook, the stock has experienced volatility, with a one-year low of $99.06, which may concern risk-averse investors.
  • Analysts have given a consensus rating of "Hold," suggesting that while the stock is stable, there may not be significant upside potential in the short term.
  • The financial services sector can be sensitive to economic downturns, and any adverse economic conditions could impact Raymond James' performance negatively.
  • Recent trading volumes have been lower than average, with only 744,741 shares exchanged compared to an average of 1,137,686, which may indicate reduced investor interest.
  • With a debt-to-equity ratio of 0.41, while relatively low, any increase in debt levels could raise concerns about financial leverage and risk, particularly in a fluctuating market.

RJF Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Raymond James is $140.91, with a high forecast of $152.00 and a low forecast of $126.00.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Raymond James in the last twelve months. There are currently 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RJF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RJF, but not buy additional shares or sell existing shares.

According to analysts, Raymond James's stock has a predicted downside of -14.99% based on their 12-month stock forecasts.

Over the previous 90 days, Raymond James's stock had 1 upgrade by analysts.

Raymond James has been rated by research analysts at Bank of America, Jefferies Financial Group, JMP Securities, Morgan Stanley, TD Cowen, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

Raymond James also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Raymond James less than other "finance" companies. The consensus rating score for Raymond James is 2.33 while the average consensus rating score for "finance" companies is 2.49. Learn more on how RJF compares to other companies.


This page (NYSE:RJF) was last updated on 12/4/2024 by MarketBeat.com Staff
From Our Partners